Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2017 017 441.6 |
96 | EP file number | EAKZ | 17 78 7843.6 |
86 | WO file number | WAKZ | PCT/US2017/055983 |
97 | EP publication number | EPN | 3523301 |
87 | WO publication number | WPN | 2018071447 |
54 | Designation/title | TI | SUBSTITUIERTE PYRAZOLO[1,5-A]PYRIDIN VERBINDUNGEN ALS RET KINASE INHIBITOREN |
51 | IPC main class | ICM (ICMV) | C07D 471/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/437 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Oct 10, 2017 |
96 | EP application date | EAT | Oct 10, 2017 |
86 | WO application date | WAT | Oct 10, 2017 |
43 | Date of first publication | OT | Apr 19, 2018 |
| Date of publication of grant | PET | May 27, 2020 |
71/73 | Applicant/owner | INH | Array Biopharma Inc., Boulder, Col., US |
72 | Inventor | IN | ANDREWS, Steven W., Boulder, Colorado 80301, US; ARONOW, Sean, Boulder, Colorado 80301, US; BLAKE, James F., Boulder, Colorado 80301, US; BRANDHUBER, Barbara J., Boulder, Colorado 80301, US; COOK, Adam, Boulder, Colorado 80301, US; HAAS, Julia, Boulder, Colorado 80301, US; JIANG, Yutong, Boulder, Colorado 80301, US; KOLAKOWSKI, Gabrielle R., Boulder, Colorado 80301, US; MCFADDIN, Elizabeth A., Boulder, Colorado 80301, US; MCKENNEY, Megan L., Boulder, Colorado 80301, US; MCNULTY, Oren T., Boulder, Colorado 80301, US; METCALF, Andrew T., Boulder, Colorado 80301, US; MORENO, David A., Boulder, Colorado 80301, US; TANG, Tony P., Boulder, Colorado 80301, US; REN, Li, Boulder, Colorado 80301, US |
74 | Representative | VTR | Office Freylinger S.A., Strassen, LU |
| Address for service | | OFFICE FREYLINGER S.A., 8001 STRASSEN, LU |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201662406252 P Oct 10, 2016
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762447850 P Jan 18, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762566093 P Sep 29, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762554817 P Sep 6, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762491164 P Apr 27, 2017
|
| Due date | FT FG | Oct 31, 2025 Annual fee for the 9th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003523301A1 Searchable text:
EP000003523301A1 Original document:
EP000003523301B1 Searchable text:
EP000003523301B1 Original document:
WO002018071447 Searchable text:
WO002018071447 |
43 | Date of first publication | EVT | Apr 19, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Aug 14, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 27, 2024 (Show all update days)(Hide all update days)- Sep 27, 2024
- Due date: changed
- Procedures: Procedure relating to PCT application, Publication of PCT application, 19.04.2018: deleted
- Sep 29, 2023; Sep 30, 2022; Sep 30, 2021; May 20, 2021; Apr 15, 2021; Sep 24, 2020; Jun 16, 2020; Jun 11, 2020; May 12, 2020; May 7, 2020; Dec 5, 2019
- Historical data not available for this/these date(s)
- Aug 14, 2019
- Date of the first transfer into DPMAregister
|